News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mazyar Shadman: Venetoclax – based therapy after cBTKi in CLL led by Nilanjan Ghosh
Mazyar Shadman and Nilanjan Ghosh
Dec 25, 2024, 03:00

Mazyar Shadman: Venetoclax – based therapy after cBTKi in CLL led by Nilanjan Ghosh

Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared on X

“Just out at American Journal of Hematology.

Venetoclax – based therapy after cBTKi in CLL led by Nilanjan Ghosh.

Kudos to the CORE team and Beenish Manzoor for building the CORE registry.

Looking forward to having more studies using CORE.”

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study

Authors: Nilanjan Ghosh, Toby A. Eyre, Jennifer R. Brown, Nicole Lamanna, Beenish S. Manzoor, Catherine C. Coombs, Hande H. Tuncer, Chaitra Ujjani, Lori A. Leslie, Lindsey E. Roeker, Matthew S. Davids, Joanna M. Rhodes, Alan P. Skarbnik, Wendy Sinai, Isabelle Fleury, Brian T. Hill, Nicolas Martinez-Calle, Paul M. Barr, Dureshahwar Jawaid, Nnadozie Emechebe, Laurie Pearson, Frederick Lansigan, Yun Choi, Christopher E. Jensen, Bita Fakhri, Deborah M. Stephens, Steven E. Marx, Stephen J. Schuster, Michael Coyle, Irina Pivneva, Talissa Watson, Annie Guerin, Mazyar Shadman

Mazyar Shadman

Alan P. Skarbnik American Journal of Hematology Annie Guerin Beenish S. Manzoor Bita Fakhri Brian T. Hill cancer Catherine C. Coombs Chaitra Ujjani Christopher E. Jensen CLL Deborah M. Stephens Dureshahwar Jawaid Frederick Lansigan Hande H. Tuncer Irina Pivneva Isabelle Fleury Jennifer R. Brown Joanna M. Rhodes Laurie Pearson Lindsey E. Roeker Lori A. Leslie Matthew S. Davids Mazyar Shadman Michael Coyle Nicolas Martinez-Calle Nicole Lamanna Nilanjan Ghosh Nnadozie Emechebe OncoDaily Oncology Paul M. Barr Stephen J. Schuster Steven E. Marx Talissa Watson Toby A. Eyre venetoclax Wendy Sinai Yun Choi
Special Coverage
Insight
Dec 25, 2024, 03:00
Mazyar Shadman: Venetoclax - based therapy after cBTKi in CLL led by Nilanjan Ghosh
Insight
Dec 25, 2024, 02:57
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Insight
Dec 25, 2024, 02:41
Correlating PSA Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment - European Urology
Science
Dec 25, 2024, 02:35
Hospital Participation in the Acute Hospital Care at Home Waiver Program by Hashem Zikry et al.
Science
Dec 25, 2024, 01:52
Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.
Blog
Dec 25, 2024, 01:50
Results of SISAQOL-IMI: Advancing Patient-Reported Outcomes Research
Science
Dec 24, 2024, 23:45
Tatiana Prowell: Genomic profiling performed on 822 breast cancer brain metastases by Athina Giannoudis et al.
Blog
Dec 24, 2024, 23:42
Extending the pandemic-era telehealth flexibilities in Medicare - ASCO
Science
Dec 24, 2024, 23:36
Drew Moghanaki: An updated report from the MISSILE study team
Science
Dec 24, 2024, 23:31
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
Insight
Dec 24, 2024, 23:29
Mark Bolton: What if patients switch treatment at progression
Blog
Dec 24, 2024, 23:27
Give the gift of hope, brighter futures, and more time for patients and families - The Leukemia And Lymphoma Society